Inventor · disambiguated record
Todd Pray
Also filed as: PRAY TODD · PRAY TODD R
12 granted patents·9 pending applications·90 citations·filing 2001–2018
89Inventor score
Files withRIGEL PHARMACEUTICALS INC9KRAFFT GRANT A3LORENS JAMES B2ACUMEN PHARMACEUTICALS INC1ISSAKANI SARKIZ D1
Top patents by PatentIndex Score
21 records- 0191US6737244B2Ubiquitin ligase assayRIGEL PHARMACEUTICALS INC·Filed 2001·Granted May 18, 2004·36 cites·43 claims
- 0288US7252952B2In vivo production of cyclic peptides for inhibiting protein—protein interactionRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Aug 7, 2007·19 cites·10 claims
- 0387US7378248B2In vivo production of cyclic peptides for inhibiting protein-protein interactionRIGEL PHARMACEUTICALS INC·Filed 2005·Granted May 27, 2008·7 cites·5 claims
- 0482US9040462B2In vivo production of cyclic peptides for inhibiting protein-protein interactionLORENS JAMES B·Filed 2008·Granted May 26, 2015·5 cites·18 claims
- 0580US6919184B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jul 19, 2005·8 cites·17 claims
- 0677US7022493B2Ubiquitin conjugation assaysRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Apr 4, 2006·10 cites·20 claims
- 0767US6979551B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Dec 27, 2005·5 cites·33 claims
- 0865US7781182B2Ubiquitin ligase assayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·0 cites·27 claims
- 0957US2007213512A1Amyloid beta peptide analogs and assemblies thereofKRAFFT GRANT A·Filed 2007·Application pending·0 cites
- 1056US2007105140A1In vivo production of cyclic peptidesLORENS JAMES B·Filed 2006·Application pending·0 cites
- 1155US7524642B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Apr 28, 2009·0 cites·17 claims
- 1254US2009263831A1Ubiquitin ligase assayISSAKANI SARKIZ D·Filed 2006·Application pending·0 cites
- 1352US2011098309A1Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compoundsACUMEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1451US2006115864A1Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1550US9006283B2Methods of modifying amyloid β oligomers using non-peptidic compoundsKRAFFT GRANT A·Filed 2007·Granted Apr 14, 2015·0 cites·7 claims
- 1650US8962677B2Methods of restoring cognitive ability using non-peptidic compoundsKRAFFT GRANT A·Filed 2007·Granted Feb 24, 2015·0 cites·1 claims
- 1746US2008113444A1Method for detecting oligermization of soluble amyloid beta oligomersPRAY TODD R·Filed 2007·Application pending·0 cites
- 1843US2004053324A1Assays and compositions for identifying agents that modulate the activity of deubiquitinating agentsFiled 2002·Application pending·0 cites
- 1942US2004043386A1Methods and compositions for functional ubiquitin assaysFiled 2002·Application pending·0 cites
- 2041US10907223B2Method to produce a polysaccharide gel by increasing the pH of the polysaccharideUNIV CALIFORNIA·Filed 2018·Granted Feb 2, 2021·0 cites·5 claims
- 2133US2008306074A1Compositions Comprising Addl Receptors, Related Compositions, and Related MethodsLACOR PASCALE N·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →